N-glycosylation of monoclonal light chains on routine MASS-FIX testing is a risk factor for MGUS progression-Reference-Cited by-同舟云学术

N-glycosylation of monoclonal light chains on routine MASS-FIX testing is a risk factor for MGUS progression

Published:2020-06-27 Issue:10 Volume:34 Page:2749-2753
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Dispenzieri Angela^ORCID,Larson D. R.,Rajkumar S. V.,Kyle R. A.,Kumar S. K.^ORCID,Kourelis Taxiarchis,Arendt Bonnie,Willrcih Maria,Dasari Surendra,Murray David

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-020-0940-8.pdf

Reference19 articles.

1. Pinho SS, Reis CA. Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer. 2015;15:540–55.

2. Bellotti V, Mangione P, Merlini G. Review: immunoglobulin light chain amyloidosis-the archetype of structural and pathogenic variability. J Struct Biol. 2000;130:280–9.

3. Milani P, Murray DL, Barnidge DR, Kohlhagen MC, Mills JR, Merlini G, et al. The utility of MASS-FIX to detect and monitor monoclonal proteins in the clinic. Am J Hematol. 2017;92:772–9.

4. Kumar S, Murray D, Dasari S, Milani P, Barnidge D, Madden B, et al. Assay to rapidly screen for immunoglobulin light chain glycosylation: a potential path to earlier AL diagnosis for a subset of patients. Leukemia. 2019;33:254–7.

5. Kourelis T, Murray DL, Dasari S, Kumar S, Barnidge D, Madden B, et al. MASS-FIX may allow identification of patients at risk for light chain amyloidosis before the onset of symptoms. Am J Hematol. 2018;93:E368–70.

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glycosylation: mechanisms, biological functions and clinical implications;Signal Transduction and Targeted Therapy;2024-08-05

2. Helical superstructures between amyloid and collagen in cardiac fibrils from a patient with AL amyloidosis;Nature Communications;2024-07-28

3. Current status and prospect of anti-amyloid fibril therapy in AL amyloidosis;Blood Reviews;2024-07

4. Serum mass spectrometry for treatment monitoring in patients with multiple myeloma receiving ARI0002h CAR T‐cells;British Journal of Haematology;2024-06-18

5. Top-down proteomics;Nature Reviews Methods Primers;2024-06-13